Efficacy News and Research

RSS
Young smokers face psychological difficulties of quitting as adults

Young smokers face psychological difficulties of quitting as adults

AtriCure receives FDA approval for surgical treatment of atrial fibrillation

AtriCure receives FDA approval for surgical treatment of atrial fibrillation

Glenmark's GBR 500 enters Phase II clinical development for severe ulcerative colitis

Glenmark's GBR 500 enters Phase II clinical development for severe ulcerative colitis

Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS

Genzyme receives FDA approval for AUBAGIO to treat relapsing forms of MS

Roughly two in five women in the U.S. do not use any form of birth control: Survey

Roughly two in five women in the U.S. do not use any form of birth control: Survey

Positive data from Tetraphase Pharmaceuticals’ eravacycline Phase 2 trial on cIAI

Positive data from Tetraphase Pharmaceuticals’ eravacycline Phase 2 trial on cIAI

Breakthrough for dengue vaccine development

Breakthrough for dengue vaccine development

Combination chemotherapy confirmed viable for penile cancer

Combination chemotherapy confirmed viable for penile cancer

MD Anderson joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

MD Anderson joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Aethic, King's College London to develop first sunscreen based on mycosporine-like amino acids

Aethic, King's College London to develop first sunscreen based on mycosporine-like amino acids

HSS receives NFL grant for research into platelet-rich plasma and stem cells

HSS receives NFL grant for research into platelet-rich plasma and stem cells

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Minimally invasive esophagectomy viable alternative to open surgery

Minimally invasive esophagectomy viable alternative to open surgery

Dengue vaccine breakthrough

Dengue vaccine breakthrough

Pergamum initiates LL-37 Phase I/II trial in hard-to-heal venous leg ulcers

Pergamum initiates LL-37 Phase I/II trial in hard-to-heal venous leg ulcers

Cell Therapeutics launches Pixuvri in the European Union

Cell Therapeutics launches Pixuvri in the European Union

Oxyphenbutazone can kill drug resistant TB

Oxyphenbutazone can kill drug resistant TB

Palatin Technologies completes bremelanotide Phase 2B trial on female sexual dysfunction

Palatin Technologies completes bremelanotide Phase 2B trial on female sexual dysfunction

Florida Hospital Tampa adopts FDA approved Trevo Pro Clot Retriever

Florida Hospital Tampa adopts FDA approved Trevo Pro Clot Retriever

HIV viruses with two genetic 'footprints' associated with greater vaccine efficacy

HIV viruses with two genetic 'footprints' associated with greater vaccine efficacy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.